Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH U.S. Food and Drug Administration Center for Devices and Radiological Health
horizonal rule
Consumer (CDRH/FDA) (Consumer Photo Montage)
Skip Consumer NavigationConsumer Home Product Information Choosing a Medical Device How We Can Help Resources Problems with Medical Devices

Synvisc

FDA cleared Synvisc G-F 20 (FDA #P940015) in August 1997 for the treatment of pain in osteoarthritis of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, e.g., acetaminophen. This device has received approval for several supplements to their original device, such as extending the treatment to 26 weeks. You can view this information by visiting our database at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm
In the space "PMA Number" enter "P940015" and all releasable information will be displayed.

Any further information should be requested directly from the manufacturer at:

Genzyme Corporation
One Kendall Square
Cambridge, MA 02139
800-745-4447

 

 

Updated September 30, 2003

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH